561 related articles for article (PubMed ID: 18598683)
1. Identification of gangliosides recognized by IgG anti-GalNAc-GD1a antibodies in bovine spinal motor neurons and motor nerves.
Yoshino H; Ariga T; Suzuki A; Yu RK; Miyatake T
Brain Res; 2008 Aug; 1227():216-20. PubMed ID: 18598683
[TBL] [Abstract][Full Text] [Related]
2. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome.
Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K
Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854
[TBL] [Abstract][Full Text] [Related]
3. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
4. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
6. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
7. GalNAc-GD1a is localized specifically in ventral spinal roots, but not in dorsal spinal roots.
Yoshino H; Utsunomiya I; Taguchi K; Ariga T; Nagaoka T; Aoyagi H; Asano A; Yamada M; Miyatake T
Brain Res; 2005 Sep; 1057(1-2):177-80. PubMed ID: 16154116
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission.
Taguchi K; Ren J; Utsunomiya I; Aoyagi H; Fujita N; Ariga T; Miyatake T; Yoshino H
J Neurol Sci; 2004 Oct; 225(1-2):91-8. PubMed ID: 15465091
[TBL] [Abstract][Full Text] [Related]
9. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
[TBL] [Abstract][Full Text] [Related]
10. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
11. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
12. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
13. Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia.
Kamakura K; Kaida K; Kusunoki S; Miyamoto N; Masaki T; Nakamura R; Motoyoshi K; Fukuda J
J Peripher Nerv Syst; 2005 Jun; 10(2):190-201. PubMed ID: 15958130
[TBL] [Abstract][Full Text] [Related]
14. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Neurology; 2003 Aug; 61(4):465-70. PubMed ID: 12939418
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
16. [Axonal Guillain-Barré syndrome associated with antibodies to Ga1NAc-GD1a and unidentified acidic glycolipids].
Ono M; Sakai T; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):119-22. PubMed ID: 9164143
[TBL] [Abstract][Full Text] [Related]
17. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
[TBL] [Abstract][Full Text] [Related]
18. [Case of pure motor Guillain-Barré syndrome with motor conduction block and anti-GM1/GalNAc-GD1a antibody].
Ogawa G; Kaida K; Shiozaki Y; Araki M; Kimura F; Kamakura K
Rinsho Shinkeigaku; 2009 Aug; 49(8):488-92. PubMed ID: 19827599
[TBL] [Abstract][Full Text] [Related]
19. Anti-ganglioside complex antibodies associated with severe disability in GBS.
Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
[TBL] [Abstract][Full Text] [Related]
20. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
